The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: potential therapy for cancer.
2001 · PubMed · 297 citations
K
Karen Affleck
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
2.9K
Citations
21
h-index
24
i10-index
Karen Affleck is an academic researcher from GlaxoSmithKline (United Kingdom). The author has contributed to research in topics: Asthma and respiratory diseases & HER2/EGFR in Cancer Research & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 21, co-authored 40 publications.
Papers by this author
worksIndazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and c-erbB-2
2001 · Bioorganic & Medicinal Chemistry Letters · 79 citations
https://doi.org/10.1016/s0960-894x(01)00219-0
P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33
2024 · International Journal of Molecular Sciences · 6 citations
https://doi.org/10.3390/ijms25031730
Dataset for: Orai and TRPC channel characterisation in FcεRI- mediated calcium signaling and mediator secretion in human mast cells
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.c.3743648.v1
Dataset for: Orai and TRPC channel characterisation in FcεRI- mediated calcium signaling and mediator secretion in human mast cells
2017 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.4880801
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat